| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.068 | 0.1 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |